Company: SABR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001597033-25-000090
Chunk: 170

Company: Sabre Corp
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 170
---
 7. Debt for further details. Until the 2026 Exchangeable Notes mature, we expect to settle the principal amount of the outstanding 2026 Exchangeable Notes in shares of our common stock. 

19

12. Earnings Per Share 

The following table reconciles the numerators and denominators used in the computations of basic and diluted earnings per share from continuing operations (in thousands, except per share data):Three Months Ended June 30,Six Months Ended June 30,2025202420252024Numerator:Loss from continuing operations$(201,018)$(69,731)$(204,395)$(136,821)Less: Net (loss) income attributable to noncontrolling interests(168)275 45 653 Net loss from continuing operations available to common stockholders, diluted$(200,850)$(70,006)$(204,440)$(137,474)Denominator:Basic weighted-average common shares outstanding390,905 383,506 388,601 381,640 Diluted weighted-average common shares outstanding390,905 383,506 388,601 381,640 Loss per share from continuing operations:Basic$(0.51)$(0.18)$(0.53)$(0.36)Diluted$(0.51)$(0.18)$(0.53)$(0.36)Basic earnings per share is computed by dividing net income from continuing operations available to common stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share is computed by dividing net income from continuing operations available to common stockholders by the weighted-average number of common shares outstanding plus the effect of all dilutive common stock equivalents during each period. The diluted weighted-average common shares outstanding calculation excludes 3 million and 8 million of dilutive stock options and restricted stock awards for the three and six months ended June 30, 2025, respectively, and 1 million and 3 million of dilutive stock options and restricted stock awards for the three and six months ended June 30, 2024, respectively, as their effect would be anti-dilutive given the net loss incurred in the period. The calculation of diluted weighted-average shares excludes the impact of 2 million of anti-dilutive common stock equivalents for the three months ended June 30, 2025, and 4 million and 3 million of anti-dilutive common stock equivalents for